Cite
Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique.
MLA
Floridia, Marco, et al. “Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique.” Clinical Infectious Diseases, vol. 65, no. 11, Dec. 2017, pp. 1878–83. EBSCOhost, https://doi.org/10.1093/cid/cix641.
APA
Floridia, M., Ciccacci, F., Andreotti, M., Hassane, A., Sidumo, Z., Magid, N. A., Sotomane, H., David, M., Mutemba, E., Cebola, J., Mugunhe, R. J., Riccardi, F., Marazzi, M. C., Giuliano, M., Palombi, L., & Mancinelli, S. (2017). Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique. Clinical Infectious Diseases, 65(11), 1878–1883. https://doi.org/10.1093/cid/cix641
Chicago
Floridia, Marco, Fausto Ciccacci, Mauro Andreotti, Archa Hassane, Zita Sidumo, Nurja A. Magid, Horacio Sotomane, et al. 2017. “Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique.” Clinical Infectious Diseases 65 (11): 1878–83. doi:10.1093/cid/cix641.